SYSTEMS AND METHODS FOR IMPLEMENTING RAPID RESPONSE MONITORING OF BLOOD CONCENTRATION OF A METABOLITE

• US 20110152653A1
• Filed: 06/07/2009
• Published: 06/23/2011
• Est. Priority Date: 06/05/2008
• Status: Abandoned Application

• Current Assignee: G-Sense Ltd.
• Original Assignee: G-Sense Ltd.
• Inventors: Peleg, Noam, Yotvat, Erez, Shekalim, Avraham
• Application Number:
  US12/996,419
• Publication Number:
  US 20110152653A1
• Time in Patent Office: Days
• US Class Current: 600/345
• CPC Class Codes: A61B 2560/063 Devices specially adapted for delivering implantable medical measuring apparatus
• CPC Class Codes: A61B 5/14525 using microdialysis
• CPC Class Codes: A61B 5/14528 invasively
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence

Abstract

Systems and methods for monitoring the concentration of glucose or other metabolites by way of a low-volume microdialysis-probe (10) operative in accordance with a pulsed mode of flow through a flow path (12) defined by a layered structure. Also described are a system and a method for deployment of the microdialysis probe (10) within the body and a technique for deriving a metabolite concentration of the basis of a rate of change of an optical parameter.

Claims

1. A method for monitoring the concentration of a metabolite in vivo within a body fluid, the method comprising the steps of:

(a) providing a monitoring device comprising;

(i) a microdialysis probe formed at least in part from a membrane permeable to the metabolite, the probe defining a probe volume containing dialysate,

(ii) a measuring cell having a measuring volume, and

(iii) a flow path connecting from the probe volume to the measuring volume;

(b) bringing the probe into contact with the body fluid;

(c) maintaining substantially zero flow conditions during a diffusion period to allow diffusion of the metabolite into the dialysate within the microdialysis probe; and

(d) generating a dialysate flow to carry a quantity of dialysate from the probe volume along the flow path to the measuring volume,

wherein said generating a dialysate flow is performed such that said quantity of dialysate passes from the probe volume to the measuring volume in a given transport time, said transport time being no more than 25 percent of said diffusion period.

3. The method of claim 1, wherein said transport time is no more than 10 percent of said diffusion period.

4. The method of claim 1, wherein said substantially zero flow conditions and said dialysate flow are generated repeatedly as part of a pulsed flow pattern, and wherein a single fluid pulse of said pulsed flow pattern transports said quantity of dialysate from the probe volume to the measuring volume.

5. The method of claim 1, wherein at least part of the flow path from the probe volume to the measuring volume is formed as a channel enclosed between at least two layers of a layered structure.

6. The method of claim 5, wherein said layered structure further comprises a reagent inlet in flow connection with said flow path for introducing a reagent for mixing with the dialysate from said probe prior to the dialysate reaching said measuring volume.

7. The method of claim 5, wherein said measuring volume is enclosed between layers of said layered structure.

8. The method of claim 7, wherein at least one of said layers enclosing said measuring volume is a transparent layer, and wherein the device further comprises an optical sensor for sensing an optical parameter of fluid within said measuring volume via said at least one transparent layer.

9. The method of claim 5, wherein said probe comprises a length of flexible tube formed primarily from said membrane permeable to the metabolite, each end of said length of flexible tube being in fluid connection with an aperture formed in at least one layer of said layered structure.

10. The method of claim 9, wherein said layered structure further comprises an insertion bore aligned with said probe for insertion of an inserter to support said probe during insertion into the body of a subject.

11. The method of claim 9, wherein the device further comprises an inserter comprising:

(a) an elongated shaft having a penetrating tip and a recess for receiving a part of said probe; and

(b) an actuator element, deployed at least partially coextensively with said elongated shaft,

wherein said elongated shaft and said actuator element are configured such that, in a first relative position of said elongated shaft and said actuator element, said inserter retains said probe for insertion through a biological barrier into tissue, and, when said actuator element is displaced relative to said elongated shaft, said probe is released, thereby allowing withdrawal of said inserter from the tissue while said probe remains inserted within the tissue.

12. The method of claim 1, wherein the device further comprises:

(a) an optical sensor deployed for sensing an optical parameter of fluid within said measuring volume; and

(b) a concentration calculator operationally connected to the optical sensor, the concentration calculator comprising at least one processor, the concentration calculator being configured to derive a rate of change of the optical parameter of the fluid within said measuring volume under substantially zero flow conditions, and to calculate a concentration of the metabolite within the body fluid based at least in part on said rate of change.

2. A device for monitoring the concentration of a metabolite in vivo within a body fluid, the device comprising:

(a) a microdialysis probe for bringing into contact with the body fluid, said probe being formed at least in part from a membrane permeable to the metabolite, said probe defining a probe volume containing dialysate;

(b) a measuring cell having a measuring volume;

(c) a flow path connecting from the probe volume to the measuring volume; and

(d) a fluid flow controller deployed to control flow of dialysate through said probe volume and said flow path to said measuring volume, said fluid flow controller being configured to generate a pulsed flow pattern including;

(i) a diffusion period of substantially zero flow conditions to allow diffusion of the metabolite into the dialysate within said probe; and

(ii) a dialysate flow to carry a quantity of dialysate from the probe volume along said flow path to the measuring volume,

wherein said flow controller generates said dialysate flow such that said quantity of dialysate passes from the probe volume to the measuring volume in a given transport time, said transport time being no more than 25 percent of said diffusion period.

23. The device of claim 2, wherein said transport time is no more than 10 percent of said diffusion period.

24. The device of claim 2, wherein said substantially zero flow conditions and said dialysate flow are generated repeatedly as part of a pulsed flow pattern, and wherein a single fluid pulse of said pulsed flow pattern transports said quantity of dialysate from the probe volume to the measuring volume.

25. The device of claim 2, wherein at least part of the flow path from the probe volume to the measuring volume is formed as a channel enclosed between at least two layers of a layered structure.

26. The device of claim 25, wherein said layered structure further comprises a reagent inlet in flow connection with said flow path for introducing a reagent for mixing with the dialysate from said probe prior to the dialysate reaching said measuring volume.

27. The device of claim 25, wherein said measuring volume is enclosed between layers of said layered structure.

28. The device of claim 27, wherein at least one of said layers enclosing said measuring volume is a transparent layer, and wherein the device further comprises an optical sensor for sensing an optical parameter of fluid within said measuring volume via said at least one transparent layer.

29. The device of claim 25, wherein said probe comprises a length of flexible tube formed primarily from said membrane permeable to the metabolite, each end of said length of flexible tube being in fluid connection with an aperture formed in at least one layer of said layered structure.

30. The device of claim 29, wherein said layered structure further comprises an insertion bore aligned with said probe for insertion of an inserter to support said probe during insertion into the body of a subject.

31. The device of claim 29, wherein the device further comprises an inserter comprising:

(a) an elongated shaft having a penetrating tip and a recess for receiving a part of said probe; and

(b) an actuator element, deployed at least partially coextensively with said elongated shaft,

wherein said elongated shaft and said actuator element are configured such that, in a first relative position of said elongated shaft and said actuator element, said inserter retains said probe for insertion through a biological barrier into tissue, and, when said actuator element is displaced relative to said elongated shaft, said probe is released, thereby allowing withdrawal of said inserter from the tissue while said probe remains inserted within the tissue.

32. The device of claim 2, wherein the device further comprises:

(a) an optical sensor deployed for sensing an optical parameter of fluid within said measuring volume; and

(b) a concentration calculator operationally connected to the optical sensor, the concentration calculator comprising at least one processor, the concentration calculator being configured to derive a rate of change of the optical parameter of the fluid within said measuring volume under substantially zero flow conditions, and to calculate a concentration of the metabolite within the body fluid based at least in part on said rate of change.

13. A device for monitoring the concentration of a metabolite in vivo within a body fluid, the device comprising:

(a) a microdialysis probe for bringing into contact with the body fluid, said probe being formed at least in part from a membrane permeable to the metabolite, said probe defining a probe volume containing dialysate;

(b) a measuring cell having a measuring volume; and

(c) a flow path connecting from the probe volume to the measuring volume,

wherein at least part of the flow path from the probe volume to the measuring volume is formed as a channel enclosed between at least two layers of a layered structure.

14. The device of claim 13, wherein said layered structure further comprises a reagent inlet in flow connection with said flow path for introducing a reagent for mixing with the dialysate from said probe prior to the dialysate reaching said measuring volume.

15. The device of claim 13, wherein said measuring volume is enclosed between layers of said layered structure.

16. The device of claim 15, wherein at least one of said layers enclosing said measuring volume is a transparent layer, and wherein the device further comprises an optical sensor for sensing an optical parameter of fluid within said measuring volume via said at least one transparent layer.

17. The device of claim 13, wherein said probe comprises a length of flexible tube formed primarily from said membrane permeable to the metabolite, each end of said length of flexible tube being in fluid connection with an aperture formed in at least one layer of said layered structure.

18. The device of claim 17, wherein said layered structure further comprises an insertion bore aligned with said probe for insertion of an inserter to support said probe during insertion into the body of a subject.

19. The device of claim 17, wherein the device further comprises an inserter comprising:

(a) an elongated shaft having a penetrating tip and a recess for receiving a part of said probe; and

(b) an actuator element, deployed at least partially coextensively with said elongated shaft,

wherein said elongated shaft and said actuator element are configured such that, in a first relative position of said elongated shaft and said actuator element, said inserter retains said probe for insertion through a biological barrier into tissue, and, when said actuator element is displaced relative to said elongated shaft, said probe is released, thereby allowing withdrawal of said inserter from the tissue while said probe remains inserted within the tissue.

20-22. -22. (canceled)